TY  - JOUR
AU  - Miehlke, Stephan
AU  - Guagnozzi, Danila
AU  - Zabana, Yamile
AU  - Tontini, Gian E
AU  - Fiehn, Anne-Marie Kanstrup
AU  - Wildt, Signe
AU  - Bohr, Johan
AU  - Bonderup, Ole
AU  - Bouma, Gerd
AU  - D’Amato, Mauro
AU  - Engel, Peter Johan Heiberg
AU  - Fernandez-Banares, Fernando
AU  - Macaigne, Gilles
AU  - Hjortswang, Henrik
AU  - Hultgren-Hörnquist, Elisabeth
AU  - Koulaouzidis, Anastasios
AU  - Kupcinskas, Jouzas
AU  - Landolfi, Stefania
AU  - Latella, Giovanni
AU  - Lucendo, Alfredo
AU  - Lyutakov, Ivan
AU  - Madisch, Ahmed
AU  - Magro, Fernando
AU  - Marlicz, Wojciech
AU  - Mihály, Emese
AU  - Munck, Lars Kristian
AU  - Ostvik, Ann-Elisabeth
AU  - Patai, Árpád V
AU  - Penchev, Plamen
AU  - Skonieczna-Żydecka, Karolina
AU  - Verhaegh, Bas
AU  - Münch, Andreas
TI  - European guidelines on microscopic colitis: United European Gastroenterology (UEG) and European Microscopic Colitis Group (EMCG) statements and recommendations
JF  - UNITED EUROPEAN GASTROENTEROLOGY JOURNAL
J2  - UEG JOURNAL
VL  - 9
PY  - 2021
IS  - 1
SP  - 13
EP  - 37
PG  - 25
SN  - 2050-6406
DO  - 10.1177/2050640620951905
UR  - https://m2.mtmt.hu/api/publication/31627940
ID  - 31627940
AB  - IntroductionMicroscopic colitis is a chronic inflammatory bowel disease characterised by normal or almost normal endoscopic appearance of the colon, chronic watery, non-bloody diarrhoea and distinct histological abnormalities, which identify three histological subtypes, the collagenous colitis, the lymphocytic colitis and the incomplete microscopic colitis. With ongoing uncertainties and new developments in the clinical management of microscopic colitis, there is a need for evidence-based guidelines to improve the medical care of patients suffering from this disorder.MethodsGuidelines were developed by members from the European Microscopic Colitis Group and United European Gastroenterology in accordance with the Appraisal of Guidelines for Research and Evaluation II instrument. Following a systematic literature review, the Grading of Recommendations Assessment, Development and Evaluation methodology was used to assess the certainty of the evidence. Statements and recommendations were developed by working groups consisting of gastroenterologists, pathologists and basic scientists, and voted upon using the Delphi method.ResultsThese guidelines provide information on epidemiology and risk factors of microscopic colitis, as well as evidence-based statements and recommendations on diagnostic criteria and treatment options, including oral budesonide, bile acid binders, immunomodulators and biologics. Recommendations on the clinical management of microscopic colitis are provided based on evidence, expert opinion and best clinical practice.ConclusionThese guidelines may support clinicians worldwide to improve the clinical management of patients with microscopic colitis.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Lőrinczy, Katalin
AU  - Lakatos, Gábor
AU  - Müllner, Katalin Edit
AU  - Hritz, István
AU  - Lakatos, Péter László
AU  - Tulassay, Zsolt
AU  - Miheller, Pál
TI  - Low bone mass in microscopic colitis
JF  - BMC GASTROENTEROLOGY
J2  - BMC GASTROENTEROL
VL  - 11
PY  - 2011
PG  - 8
SN  - 1471-230X
DO  - 10.1186/1471-230X-11-58
UR  - https://m2.mtmt.hu/api/publication/1541374
ID  - 1541374
N1  - Megjegyzés-22799082
Megjegyzés-21550837
WC: Gastroenterology & Hepatology
Cited By :5            
            Export Date: 12 March 2020            
            CODEN: BGMAB            
            Correspondence Address: Miheller, P.; Department of Medicine, Semmelweis University, Budapest, Hungary; email: mihpal@yahoo.co.uk            
            Chemicals/CAS: azathioprine, 446-86-6; mesalazine, 89-57-6; osteocalcin, 136461-80-8; Osteocalcin, 104982-03-8
LA  - English
DB  - MTMT
ER  -